Notwithstanding, a recent study showed that adding an NADPH inhibitor (diphenyleneiodonium) or a PAD inhibitor (chloramidine) to SLE patients’ sera did not affect NET formation, which suggests that excessive NET formation in SLE may be independent of NADPH and PAD4 at least under certain circumstances. Here, PADI4 is linked to systemic lupus erythematosus.